And our adjusted earnings per share was $0.43, higher than the prior year by over 200%.
Second-quarter sales declined by $39 million or 8% compared to the prior year, driven mostly by the global pandemic and associated economic conditions.
We expect our net sales to be down between 7% and 12% from the prior year.
And for adjusted EBITDA to be in a range of $155 to $165 million.
We also expect higher capital spending in the second half of the fiscal year along with some working capital growth in-line with the recovery.
